Rachel S. Rubin, MD I’m Dr Rachel Rubin. I am a urologist with fellowship training in sexual medicine. Today I’m going to explain why I may recommend that your patients put a needle directly into their penises for help with erectile dysfunction (ED). I know that sounds crazy, but in a recent video when I...
Category: <span>Editorial</span>
Post
How to Prescribe Zepbound
Beverly Tchang, MD December marks the advent of the approval of tirzepatide (Zepbound) for on-label treatment of obesity. In November 2023, the US Food and Drug Administration (FDA) approved it for the treatment of obesity in adults. In May 2022, the FDA approved Mounjaro, which is tirzepatide, for type 2 diabetes. Since then, many physicians,...
Post
How to Prescribe Zepbound
Beverly Tchang, MD December marks the advent of the approval of tirzepatide (Zepbound) for on-label treatment of obesity. In November 2023, the US Food and Drug Administration (FDA) approved it for the treatment of obesity in adults. In May 2022, the FDA approved Mounjaro, which is tirzepatide, for type 2 diabetes. Since then, many physicians,...
Post
Renal Cell Carcinoma: 5 Things to Know for Primary Care
Karl J. D’Silva, MDDISCLOSURES Renal cell carcinoma (RCC) represents up to 85% of kidney cancers. It is considered the deadliest urologic cancer in the United States, with a 5-year survival rate of 76% overall, going down to only 12% for patients with late-stage disease. Here are five things that primary care clinicians should know about...
Post
What to Tell Your Patients About Anti-amyloids for Alzheimer’s Disease
Kathrin LaFaver, MD; Meredith Wicklund, MDDISCLOSURES This transcript has been edited for clarity. Kathrin LaFaver, MD: Hi. My name is Kathrin LaFaver. I’m a neurologist in Saratoga Springs, New York. I’ll be talking on behalf of Medscape today with Dr Meredith Wicklund, who is a senior associate consultant and behavioral neurologist specialist at Mayo Clinic...
Post
Hematuria: When to Worry About Bloody Urine
Matthew F. Watto, MD; Paul N. Williams, MDDISCLOSURES Matthew F. Watto, MD: Welcome back to The Curbsiders. I’m Dr Matthew Watto, here with Dr Paul Nelson Williams. We’re going to be recapping some of our favorite pearls on hematuria, which is a really common problem. Gross hematuria — should we worry about it? Paul N....
Post
GLP-1 Agonists and Suicide Risk: What Action Should Be Taken?
Boris Hansel, MD, PhDDISCLOSURES September 20, 2023 A statement from the European Medicines Agency (EMA) about semaglutide and, more generally, glucagon-like peptide 1 (GLP-1) agonists recently caused a stir. Could these medicines lead to patients taking their own lives?Medical Authorities Alert The EMA published a press release in early July 2023 to announce that a review is...
Post
Debate: Is Lasting Remission of Type 2 Diabetes Feasible in the Real-World Setting?
Kevin Fernando, MBChB, MScDISCLOSURES October 17, 2023 The prospect of remission of type 2 diabetes (T2D) has captured the hearts and minds of many patients with T2D and healthcare professionals, including myself. Kevin Fernando, MBChB, MSc I have changed my narrative when supporting my patients with T2D. I used to say that T2D is a progressive condition,...
Post
Understanding Consciousness Goes Beyond Exploring Brain Chemistry
We can account for the evolution of consciousness only if we crack the philosophy, as well as the physics, of the brain By Philip Goff on November 7, 2023 The science of consciousness has not lived up to expectations. Over the summer, the neuroscientist Christof Koch conceded defeat on his 25-year bet with the philosopher David Chalmers, a...
Post
What Not to Prescribe to Older Adults and What to Use Instead
Neil Skolnik, MDDISCLOSURES November 08, 2023 I’m Dr Neil Skolnik. Today we are going to talk about the American Geriatrics Society 2023 updated Beers Criteria guidance for medication use in older adults. These criteria have been updated and revised approximately every 5 years since 1991 and serve to alert us to medications for which the risk-benefit ratio...